John R. Ohlfest

5.4k total citations
65 papers, 4.2k citations indexed

About

John R. Ohlfest is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, John R. Ohlfest has authored 65 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 27 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in John R. Ohlfest's work include Immunotherapy and Immune Responses (24 papers), Virus-based gene therapy research (12 papers) and Glioma Diagnosis and Treatment (12 papers). John R. Ohlfest is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), Virus-based gene therapy research (12 papers) and Glioma Diagnosis and Treatment (12 papers). John R. Ohlfest collaborates with scholars based in United States, China and Canada. John R. Ohlfest's co-authors include William F. Elmquist, Sagar Agarwal, Ramola Sane, Stacy A. Decker, Mitsugu Fujita, Gary Kohanbash, Hideho Okada, Jose L. Gallardo, David A. Largaespada and Walter C. Low and has published in prestigious journals such as Blood, Bioinformatics and The Journal of Immunology.

In The Last Decade

John R. Ohlfest

65 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John R. Ohlfest United States	36	1.7k	1.5k	1.5k	891	511	65	4.2k
Jian Qiao United States	27	1.6k 0.9×	1.1k 0.8×	1.5k 1.0×	440 0.5×	868 1.7×	52	3.2k
Mahua Dey United States	29	1.5k 0.9×	1.0k 0.7×	1.5k 1.0×	1.3k 1.5×	294 0.6×	76	3.6k
Per Øyvind Enger Norway	32	1.2k 0.7×	1.4k 1.0×	650 0.4×	1.1k 1.3×	184 0.4×	66	3.6k
Achim Temme Germany	36	1.5k 0.9×	2.3k 1.6×	1.1k 0.8×	341 0.4×	463 0.9×	105	4.4k
Peter E. Fecci United States	38	2.4k 1.5×	1.1k 0.7×	2.2k 1.5×	2.1k 2.3×	346 0.7×	150	5.2k
Hrvoje Miletić Norway	40	1.1k 0.7×	2.5k 1.7×	707 0.5×	1.7k 1.9×	558 1.1×	118	5.3k
Nhan L. Tran United States	46	1.4k 0.8×	3.6k 2.4×	838 0.6×	986 1.1×	289 0.6×	114	6.2k
Magnus Essand Sweden	34	1.9k 1.1×	1.6k 1.1×	1.4k 0.9×	251 0.3×	1.1k 2.1×	124	4.1k
Liliana Soroceanu United States	31	1.3k 0.8×	3.0k 2.0×	799 0.5×	1.7k 1.9×	766 1.5×	46	6.0k
Lynn G. Feun United States	39	1.8k 1.1×	2.2k 1.5×	679 0.5×	647 0.7×	562 1.1×	207	5.7k

Countries citing papers authored by John R. Ohlfest

Since Specialization

Citations

This map shows the geographic impact of John R. Ohlfest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Ohlfest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Ohlfest more than expected).

Fields of papers citing papers by John R. Ohlfest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Ohlfest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Ohlfest. The network helps show where John R. Ohlfest may publish in the future.

Co-authorship network of co-authors of John R. Ohlfest

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Ohlfest. A scholar is included among the top collaborators of John R. Ohlfest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Ohlfest. John R. Ohlfest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soroceanu, Liliana, Lisa Matlaf, Armin Akhavan, et al.. (2015). Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. Cancer Research. 75(15). 3065–3076. 68 indexed citations

Hexum, Joseph K., et al.. (2015). Parthenolide prodrug LC-1 slows growth of intracranial glioma. Bioorganic & Medicinal Chemistry Letters. 25(12). 2493–2495. 15 indexed citations

Kohanbash, Gary, Masashi Sakaki, Ryo Ueda, et al.. (2013). GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α. Cancer Research. 73(21). 6413–6423. 134 indexed citations

Pluhar, G. Elizabeth, Charles E. Seiler, Michelle R. Goulart, et al.. (2013). Vaccination for Invasive Canine Meningioma Induces In Situ Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity. Cancer Research. 73(10). 2987–2997. 37 indexed citations

Lechner, Melissa G., Keegan Barry-Holson, Trevor E. Angell, et al.. (2013). Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy. Journal of Immunotherapy. 36(9). 477–489. 268 indexed citations

Murphy, Katherine A., Melissa G. Lechner, Flavia E. Popescu, et al.. (2012). An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas. Clinical Cancer Research. 18(17). 4657–4668. 29 indexed citations

Agarwal, Sagar, Rajendar K. Mittapalli, Jose L. Gallardo, et al.. (2012). Active Efflux of Dasatinib from the Brain Limits Efficacy against Murine Glioblastoma: Broad Implications for the Clinical Use of Molecularly Targeted Agents. Molecular Cancer Therapeutics. 11(10). 2183–2192. 77 indexed citations

Fujita, Mitsugu, Gary Kohanbash, Wendy Fellows-Mayle, et al.. (2011). COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells. Cancer Research. 71(7). 2664–2674. 315 indexed citations

Olin, Michael R., Brian M. Andersen, Adam J. Litterman, et al.. (2011). Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells. Cancer Research. 71(21). 6583–6589. 17 indexed citations

10.

Agarwal, Sagar, Ramola Sane, Rajneet K. Oberoi, John R. Ohlfest, & William F. Elmquist. (2011). Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Reviews in Molecular Medicine. 13. e17–e17. 233 indexed citations

11.

Fujita, Mitsugu, Michael E. Scheurer, Stacy A. Decker, et al.. (2010). Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans. Clinical Cancer Research. 16(13). 3409–3419. 76 indexed citations

12.

Agarwal, Sagar, Ramola Sane, John R. Ohlfest, & William F. Elmquist. (2010). The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain. Journal of Pharmacology and Experimental Therapeutics. 336(1). 223–233. 131 indexed citations

13.

Wiesner, Stephen M., Stacy A. Decker, Jon D. Larson, et al.. (2009). De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA. Cancer Research. 69(2). 431–439. 119 indexed citations

14.

Ohlfest, John R., Zoltán Ivics, & Zsuzsanna Izsvák. (2009). Transposable Elements as Plasmid-Based Vectors for Long-Term Gene Transfer into Tumors. Methods in molecular biology. 542. 105–116. 3 indexed citations

15.

Xiong, Zhengming, et al.. (2008). Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis. Clinical Cancer Research. 14(17). 5484–5493. 18 indexed citations

16.

Wu, Anhua, Seunguk Oh, Katya Ericson, et al.. (2007). Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Therapy. 14(6). 550–560. 34 indexed citations

17.

Candolfi, Marianela, Kurt M. Kroeger, G. Elizabeth Pluhar, et al.. (2007). ADENOVIRAL-MEDIATED GENE TRANSFERINTO THE CANINE BRAIN IN VIVO. Neurosurgery. 60(1). 167–178. 10 indexed citations

18.

Wu, Anhua, Jing Xiao, Katya Ericson, et al.. (2006). Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. Journal of Neuro-Oncology. 83(2). 121–131. 116 indexed citations

19.

Ohlfest, John R., Andrew Freese, & David A. Largaespada. (2005). Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies. Current Gene Therapy. 5(6). 629–641. 35 indexed citations

20.

Ohlfest, John R., Zachary L. Demorest, Yasuhiko Motooka, et al.. (2005). Combinatorial Antiangiogenic Gene Therapy by Nonviral Gene Transfer Using the Sleeping Beauty Transposon Causes Tumor Regression and Improves Survival in Mice Bearing Intracranial Human Glioblastoma. Molecular Therapy. 12(5). 778–788. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact